A phosphotriester solid phase method on a polyamide support has been used to prepare oligodeoxyribonucleotides up to 12 units long. Compared to solid phase phosphodiester synthesis the new methodology is quicker, more flexible and gives 10-60-fold better overall yields.
INTRODUCTION Previous papers in this series
have demonstrated the practical value of polydimethylacrylamide resins for the solid-phase synthesis of oligodeoxyribonucleotides. In these syntheses appropriate monomer units were coupled to the resin using a phosphodiester approach. Good coupling yields could be maintained provided that highly purified monomer units were used . However, isolated yields of deprotected oligonucleotides decreased rapidly as a function of chain length owing to substantial accumulation of by-products. These we attribute mostly to the susceptibility of each phosphodiester bond to reaction with active phosphorylating agent during successive coupling steps .
For some time we have felt that a phosphotriester approach applied to our polyamide resins might hold distinct advantages in terms of overall yields, speed of synthesis and length of oligonucleotide attainable, but only recently has sufficiently reliable solution methodology emerged , particularly with regard to deprotection of phosphotriesters at the end of the synthesis .
Although a phosphotriester approach on solid phase has been attempted several times in the past , only the very recently described synthesis of oligothymidylates on a polyacryloylmorpholide resin has been at all encouraging . We now describe the solid phase synthesis of the octanucleotides,
d(T-C-T-G-G-T-T-T), d(C-C-T-C-C-T-G-C), d(T-T-C-C-C-A-C-C) and d(C-T-C-C-C-A-C-C) and the dodecanucleotides, d(C-T-C-C-C-A-C-C-A-T-T-T) and d(T-T-C-C-C-A-C-C-A-T-T-T),
obtained in good overall isolated yields using a phosphotriester approach.
DISCUSSION
The Polymeric Support. The principles behind the choice of polydimethyl-1 9 acrylamide resins have been discussed at length
. Recently we introduced a new functional monomer, acryloylsarcosine methyl ester, which when copolymerised with dimethylacrylamide and ethylene bisacrylamide gave beaded resins in easily handlable form . In peptide synthesis on polydimethylacrylamide resins it has been standard practice to incorporate a reference amino acid on the resin before starting chain assembly . Yields may then be estimated by measurement of amino acid content of resin-bound peptides normalised to the value of the reference, hence eliminating errors associated with increase in resin weight. In oligonucleotide synthesis we now find that use of a reference amino acid allows easy measurement of overall yields of oligonucleotides. In addition functional groups (such as 4,4-dimethoxytrityl) can be assayed with respect to the amino acid content of the resin to give a useful guide to the efficiency of coupling reactions.
The new resin is functionalised by treatment with ethylene diamine at room temperature and the resultant amino groups then reacted with the symmetrical anhydride of t-butyloxycarbonylglycine in IMF (Pig. 1). After washing the resin (gly 0.28-0.35 mmole g~ ) may be dried and stored.
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The Resin-Polymer Linkage. In our phosphodiester approach a reversible linkage was obtained by reaction of a suitably protected 2'-deoxynucleoside-5'-phosphate with a resin-bound (J-hydroxyethylthiophenol derivative . The resultant phosphodiester could be cleaved by oxidation to the corresponding sulphone followed by base-catalysed elimination. Whereas this linkage was stable indefinitely in the presence of pyridine an analogous 3'-phosphotriester linkage formed by coupling of the hydroxy-resin with (HeO) 2 TrdT-(ClPh) was £a 30% cleaved in one week at room temperature in pyridine and was therefore judged unsuitable.
Among other base-labile linkages nucleoside derivatives have been attached 12 to succinylated polystyrene resins as 5'-0-esters . In line with our proposed chain extension procedure we wished to attach the first nucleoside residue via its 3' position . To avoid the possibility of unsubstituted and potentially deleterious carboxylic acids remaining on the resin appropriate 2'-deoxynucleoside derivatives were themselves succinylated and then coupled to the resin. Accordingly (MeO)pTrdT, (MeO) 2 TrdbzA, (HeO) 2 TrdbzC and (MeO) 2 TrdibG were each treated with succinic anhydride in the presence of 4-dimethylaminopyridine in IMP for 20 h at room temperature and the corresponding 3'-0-succinates isolated as their pyridinium salts following preparative layer chromatography. In the presence of dicyclohexylcarbodiimide in dichloromethane the succinates readily formed their respective symmetrical anhydrides which, after removal of dicyclohexylurea, were reacted in IMP with amino groups on the resin liberated by acidic cleavage of t-butyloxycarbonyl protecting groups and neutralisation (Pig. 2). Completion of reaction was (Fig. 5) . These reactions alter-
nate with terminal 5'-deprotection using f<h benzene sulphonic acid in chloroform/methanol (7:3) • Each complete synthetic cycle can be carried out in 5-6 h using a bench-top manual solvent delivery system or a modified Beckman 2 17 99OB Solid Phase Peptide Synthesiser ' using essentially similar operations (Table 1 , Experimental Section). For oligonucleotides containing N-benzoyl adenine the minimum of acidic treatment is vital to prevent depurination. In the syntheses described below two 30s treatments followed by rapid resin washing were sufficient for complete deprotection without concomittant depurination, but the precise limits of this procedure in the case of adeninerich oligonucleotides have yet to be determined. In contrast to the phospho-1 2 diester approach resin drying with phenyl isocyanate ' is not necessary during synthesis, although a precautionary 30m treatment is given at the start of the synthesis. The completely deprotected oligonucleotide is purified by ion-exchange 2 3 hplc . This is particularly advantageous in that in contrast to reversed phase hplc the desired oligonucleotide is always eluted later than any truncated or failure sequence and can be readily identified. After desalting the product is then assayed for purity by reversed phase hplc on (i-Bondapak C18 ' 19 32 and by sequencing of P-labelled samples. Synthesis of Oligonucleotides. Three alternative strategies were investi- In the synthesis of the other three octanucleotides (Table 2 ) deprotection procedure B was used throughout and the chromatographic patterns (Figs. 7-9) all show clear product peaks (yields 4.1-7.8%).
In the synthesis of the dodecanucleotides d(T-T-C-C-C-A-C-C-A-T-T-T) and d(C-T-C-C-C-A-C-C-A-T-T-T)
the assembly strategy involved use of both monomers and preformed blocks (Fig. 5? D ) . Whereas deprotection procedure A was adequate for shorter chain intermediates (Table 3) overall yields of dodecamers dropped to 1.7 and 1.2% respectively. In the latter case use of 
Fig. 6. Chromatographio patterns of the octanucleotide d(T-C-T-G-G-T-T-T')
following deprotection proceduxea A and B. approach to the synthesis of both adenine-rich and longer oligonucleotides and believe that this rapid methodology will find wide application in the preparation of biologically useful oligonucleotides.
EXPEKEMEHTAL SECTION Unless otherwise mentioned materials and methods are as previously described . 4,4-Dimethoxytrityl chloride and p-chlorophenylphosphorodichloridate were obtained from Lancaster Synthesis, 1,2,4-triazole, 1-H tetrazole, 3-hydroxypropionitrile and 4-dimethylaminopyridine from Aldrich, succinic anhydride from BDH, benzenesulphonic acid, electronic grade, from Eastman, thymidine from Sigma, deoxyadenosine from Calbiochem, deoxyguanosine and deoxycytidine hydrochloride from Leon Laboratories, St. Louis. KochLight were suppliers of 1,1,3,3,-tetramethylguanidine and p-nitrobenzyl alco- 22 23 hoi from which p-nitrobenzaldehyde and then p-nitrobenzaldoxime were prepared. Fully protected nucleoside and oligonucleotide phosphotriester building blocks were prepared essentially as previously described^' . Silica gel column chromatography was carried out on a Waters prep. LC/system 500 using methanol/dichloromethane solvent mixtures or on a Merck Lobar column, size C, using methanol/chloroform-0.5% pyridine eluants. Removal of cyano-25 ethyl protecting groups followed the procedure of Sood and Karang except that the phosphodiester products were freed from cyanoethanol by partition between chloroform and saturated brine. The organic phase was evaporated and product precipitated with diethyl ether/n-pentane (3:2). Hplc was carried out using an Altex modular system consisting of two 110 pumps, 420 system controller and 210 deluxe injection valve. Column effluents were monitored by a Cecil 212A UV photometer linked to a Tekman TE 220 recorder. Partisil 10SAX columns (PXS-analytical or M9-preparative, Whatman) were eluted with gradients of potassium phosphate (pH 6.5)/5% ethanol from 1 mil (pump A) to All resin treatments were carried out in an all-glass reaction vessel as 1 2 previously described using a bench-top valve system ' or a modified Beckman 2 16 99OB solid phase peptide synthesiser ' . Resin prefunctionalisation was carried out in a 200 ml capacity vessel using 140 ml solvent per wash. Resin Oligonucleotide Assembly. The resin is washed with (1) 5 x pyridine, 2 min, (2) 1 x 10% phenylisocyanate/pyridine, 30 min, (3) 5 * pyridine, 2 min, followed by the appropriate number of synthetic coupling cycles (Table 1) .
Deprotection and Cleavage from the Resin. Procedure A. The resin sample is treated with concentrated ammonia (1 ml per 10 mg resin) for 5 h at 50°, the liquid decanted and resin washed with ethanol/water (1:1) (3 x 1 ml) .
The decantate and washings are evaporated to dryness and the residue treated with acetic acid/water (4:1; 1 ml) for 30 min at room temperature. After TABLE 1 Step 1 The extended washing procedure is necessary to ensure reproducible removal of pyridine, which would otherwise neutralise the acid subsequently added.
An orange colour is immediately liberated into solution on addition of the acid.
For oligonucleotides containing adenine steps 3 and 4 are repeated (usually once) until no further orange colour is seen. A sample of dried resin can also be assayed for trityl content.
The nucleoside or oligonucleotide 3'-phosphate (5 equivs) is dried by coevaporation three times with anhydrous pyridine and in a dry box triisopropylbenzene sulphonyltetrazole (8.75-10 equivs) added. After 5-10 min the mixture is introduced to the resin (1 equiv as glycine) via the Teflon feed lines^>2 or by Pasteur pipette.
10 Washes are usually given in automatic operation. The programme also contains an instruction to hold until the operator is ready to begin again at step 1.
evaporation the product is dissolved in ethanol/water (1:1) ready for hplc.
Procedure B. The resin sample is shaken with 0.5 M tetramethylguanidinium p-nitrobenzaldoximate in dioxan/water (1:1) (1 ml per 10 mg resin) for 15-18 h, the liquid decanted and resin washed with dioxan/water (1:1 ) (5 x 1 ml) . The decantate and washings are carefully neutralised with acetic acid, washed with chloroform (1 ml) and the aqueous phase evaporated to dryness. The residue is treated with concentrated ammonia (1 ml) at 50° for 5 h, evaporated to dryness and treated with acetic acid/water (4:1; 1 ml) for 30 min. After evaporation the product is dissolved in ethanol/water (1:1) ready for hplc.
The Octanucleotide d(T-C-T-G-G-T-T-T)
. Resin (0.354 g, 0.109 mmole glycine) was derivatised as described above to obtain the 5'-0-dimethoxytritylthymidine-3'-0-succinamido resin (trityl 0.252 mmole g" ; trityl/gly 1.07). Seven cycles of nucleotide addition were carried out using the Beckman synthesiser and appropriate monomer units only. The Octanucleotide d(C-C-T-C-C-T-G-C). Resin (0.139 g, 0.043 mmole glycine) was derivatised as described above to obtain the 5'-O-dimethoxytrityl-N -benzoyl-2'-deoxycytidine-3'-0-succinamido resin (trityl O.27O mmole g~ , trityl/gly 1.27). Using the manual solvent delivery system one cycle of assembly was carried out with (MeO) 2 TrdibG-(ClPh) in the coupling step followed by three cycles using in order the dinucleotide blocks (MeO)pTrdbzC 2T-(ClPh), (MeOJ 2 TrdT2bzC-(ClPh) and (MeO) 2 Trdbzc2bzC-(ClPh). Trityl/gly values of resin samples at each stage were 1.55, 1.02, 0.95 and 0.54 respectively. A sample of final resin (16-59 mg» 2.578 (mole Gly) was treated according to cleavage procedure B and the product chromatographed on Partisil 10SAX (Fig. 7, 3 1.148). ji-Bondapak C18 hplc assay showed 9096 purity. The sequence was 32 confirmed by standard analysis of a P-labelled sample.
The Octanucleotides d(T-T-C-C-C-A-C-C) and d(C-T-C-C-C-A-C-C). Resin (0.154 g, O.O476 mmole Glycine) was derivatised as described above to obtain the 5'-0-dimethoxytrityl-N -benzoyl-2'-deoxycytidine-3'-0-succinamido resin (trltyl 0.258 mmole g~ , trityl/gly 1.05). Using the manual solvent delivery system one cycle of assembly was carried out with (MeO) 2 TrdbzG-(ClPh), one wtfh (MeO) 2 Trdbzc2bzc2bzA-(ClPh) and one cycle with the dinucleotide block (Me0) 2 TrdT2bzC-(ClPh). Trityl/gly values at each stage were 0.92, O.64 and 0.61 respectively. The resin was divided into two approximately equal portions. With each portion one cycle of assembly was carried out using (MeO),,TrdT-(Cl Ph) in the coupling step in one case and (MeO) 2 TrdbzC-(ClPh) in the other. A sample of the former final resin (9.765 mg, 1.925 nmole Gly) was treated according to cleavage procedure B and the product chromatographed on Partisil 10SAX (Fig. 8, 2 (i-Bondapak C18 hplc assay showed 94% purity. A sample of the latter final resin was treated according to cleavage procedure B and the product chromatographed on Partisil 10SAX (Fig. 9, 2 injections, elution 6 min 5% B, 18 min 5-35% B, 27 min 35-45% B). The material in the product peak was desalted to give 27.6 A 2 g Q units (O.4O6 Mmole, overall yield 7.8%, A max 268 nm, 260/280 1.265 calc. 1.298). jj-Bondapak C18 hplc assay showed 95% purity. The sequences of both octanucleotides were confirmed by standard analysis.
The Dodecanucleotides d(T-T-C-C-C-A-C-C-A-T-T-T) and d(C-T-C-C-C-A-C-C-A-T-T-T)
. Resin (0.354 g. 0.109 mmole, Glycine) was derivatised as described above to give the 5'-0-dimethoxytritylthymidine-3'-0-succinamido resin (trityl 0.250 mmole g" , trityl/gly O.97). Using the manual solvent delivery system two cycles of assembly were carried out with (MeO) 2 TrdT-(ClPh) in the coupling steps. Trityl/gly values at each stage were 0.82 and 0.81 respectively. Using part of the resin (0.237 g» 0.049 mmole) two further cycles of assembly were carried out with the trinucleotide block (MeO) 2 Trdbzc2bzC2bzA-(ClPh) in the coupling steps followed by one cycle with the dinucleotide block (MeO)_TrdT2bzC-(ClPh). The resin was divided into two approximately equal portions. With each portion one cycle of assembly was carried out using (MeO) 2 TrdT-(ClPh) in the coupling step in one case and (MeO) 2 TrdbzC-(Cl Ph) in the other. Isolation of oligonucleotides at various stages of synthesis is summarised in Table 3 
